Location History:
- Nagoya, JP (2014)
- Aichi, JP (2003 - 2017)
Company Filing History:
3 out of 191 
2 out of 371 
1 out of 19 Years Active: 2003-2017
Title: Innovator Yukihiro Matsuyama: Pioneering Advances in Neuropathic Pain Treatment
Introduction: Yukihiro Matsuyama is an esteemed inventor based in Aichi, Japan, recognized for his groundbreaking inventions in the field of neuropathic pain treatment. With a total of four patents to his name, Matsuyama's work focuses on developing alternative substances that provide relief from pain caused by nerve damage.
Latest Patents: Among his latest contributions are two notable patents aimed at treating neuropathic pain. The first patent, titled "Agent for neuropathic pain," introduces a lyase enzyme that degrades chondroitin sulfate chains in a specific proteoglycan. This innovation is designed to improve neuropathic pain while minimizing interactions and adverse reactions associated with current treatments. The second patent, "Method for treating neuropathic pain," involves an endo-β-N-acetylglucosaminidase type enzyme that effectively hydrolyzes bonds within the keratan sulfate backbone. This invention facilitates clinical improvements in motor neuron dysfunction and sensory neuron issues, including complications like allodynia and hyperalgesic reactions.
Career Highlights: Yukihiro Matsuyama's professional journey includes fruitful collaborations with esteemed organizations, notably Seikagaku Corporation and Nagoya University. These affiliations have enabled him to further his research and innovations in the management of neuropathic pain.
Collaborations: Throughout his career, Matsuyama has collaborated with notable colleagues, such as Kenji Kadomatsu and Akiomi Tanaka. These partnerships have contributed to the advancement of knowledge and development of effective treatments for conditions related to nerve damage.
Conclusion: Yukihiro Matsuyama's contributions to the field of neuropathic pain treatment showcase his dedication to innovation and excellence. His patents represent significant advancements in finding alternative solutions to manage pain, indicating a future where patients may have access to improved therapies with fewer side effects. As research continues, Matsuyama's work will likely inspire further developments in the medical field.